de Toledo Baldi E, Dias Bóbbo V C, Melo Lima M H, Velloso L A, Pereira de Araujo E
Obesity and Comorbidities Research Center (OCRC) University of Campinas Campinas São Paulo Brazil; Faculty of Nursing University of Campinas Campinas São Paulo Brazil.
Faculty of Nursing University of Campinas Campinas São Paulo Brazil.
Obes Sci Pract. 2016 Jun;2(2):210-214. doi: 10.1002/osp4.47. Epub 2016 May 30.
Obesity has emerged as major public health problem leading to increased morbidity and mortality. Epidemiological studies indicate that in many regions of the world, children and teenagers are increasingly affected by obesity, which contributes for a pessimistic projection for the near future. Maternal obesity has been implicated in metabolic disorders of the offspring, but there are no biological markers that can be detected early on life that predict the development of obesity in the offspring.
To evaluate the expression of inflammatory markers in the umbilical cord blood of babies of mothers with obesity/overweight, and correlate these markers with the body weight at age 9 months.
Anthropometric data of mothers and babies were obtained during prenatal evaluation, at birth and 9 months after birth. Cord blood was collected during delivery of 54 babies from mothers with obesity/overweight and of 50 babies from lean mothers. Tumour necrosis factor-alpha (TNF-α), transforming growth factor 1 beta, monocyte chemoattractant protein-1 and 2 (MCP-1/MCP-2) were determined in serum samples using enzyme-linked immunosorbent assay methods. Correlations were evaluated using the Spearman correlation coefficient, and comparisons were evaluated using the non-parametric Mann-Whitney -test.
Cord blood TNF-α was positively correlated with maternal body mass index. There was an inverse correlation between cord blood transforming growth factor 1 beta and baby body weight at birth. There was no biological marker that predicted body weight at age 9 months.
Although we have not found a biological marker to predict increased body weight at 9 months of age, the study shows that maternal obesity exposes the baby to higher TNF-α level in the early stages of life, and this can affect metabolic and inflammatory parameters during adulthood.
肥胖已成为导致发病率和死亡率上升的主要公共卫生问题。流行病学研究表明,在世界许多地区,儿童和青少年受肥胖影响的情况日益严重,这对近期前景造成了悲观的预测。母体肥胖与后代的代谢紊乱有关,但尚无在生命早期就能检测到的生物标志物可预测后代肥胖的发生。
评估肥胖/超重母亲所生婴儿脐带血中炎症标志物的表达,并将这些标志物与9个月龄时的体重相关联。
在产前评估、出生时及出生后9个月获取母亲和婴儿的人体测量数据。在54名肥胖/超重母亲所生婴儿及50名瘦母亲所生婴儿分娩时采集脐带血。采用酶联免疫吸附测定法测定血清样本中的肿瘤坏死因子-α(TNF-α)、转化生长因子1β、单核细胞趋化蛋白-1和2(MCP-1/MCP-2)。使用Spearman相关系数评估相关性,使用非参数Mann-Whitney检验评估比较结果。
脐带血TNF-α与母体体重指数呈正相关。脐带血转化生长因子1β与出生时婴儿体重呈负相关。没有生物标志物可预测9个月龄时的体重。
尽管我们未找到可预测9个月龄时体重增加的生物标志物,但该研究表明,母体肥胖使婴儿在生命早期暴露于较高的TNF-α水平,这可能会影响成年期的代谢和炎症参数。